BioCentury
ARTICLE | Company News

Merus Labs International deal

June 11, 2012 7:00 AM UTC

Merus signed a letter of intent with an undisclosed pharmaceutical company for rights to manufacture and commercialize a branded therapeutic. Merus said the drug, which is sold in the EU and Canada, h...